Representation of Medical Marijuana Treatment Center in Sale of Equity Interests
Representation of Healthy Pharms, Inc., in connection with the sale of all of the issued and outstanding equity interests to 4Front Holdings LLC.
AION Partners Joint Venture Agreements
Advised AION Partners, a leading private real estate investment firm, and negotiated related complex joint venture arrangements, in connection with AION’s acquisition of a 4,035-unit apartment portfolio with properties in New Jersey, Pennsylvania and Delaware.
Annie's, Inc. $109.25M Initial Public Offering
Represented Annie’s, Inc. in its $109.25M initial public offering (Credit Suisse Securities (USA) LLC and J.P. Morgan Securities LLC were the joint book-running managers and representatives of the underwriters for the offering); Represented Annie’s, Inc. in a secondary offering of shares of common stock to be sold exclusively by participating selling stockholders, including an over-allotment allocation that was exercised in full.
Fortune 50 Life Science Company Acquisitions
Representation of a Fortune 50 life science company in connection with acquisitions of biotechnology, biomedical, and analytic instrumentation targets.
London-Based Public Company Acquistion
Represented the U.S. subsidiary of a London-based public company in its acquisition of all of the issued and outstanding capital stock of a U.S.-based leading business-to-business account wagering solutions provider.
Interconnect Solution Design Company Acquisitions
Representation of a 70-year old leader in the design and manufacture of interconnect solutions in its acquisition of a manufacturer of wire harnesses, cable assemblies, and electro-mechanical assemblies for power management and ruggedized industrial end markets. Also represented the company in its acquisition of a manufacturer of high-quality products for trainline communication/ control connectors and harness assemblies for the transportation industry.
Clinical Development Oncology Company Series B-1 Preferred Stock and Warrants
Represented a venture-backed, late-stage clinical development oncology company focused on an epigenetic approach to overcoming the problem of resistance in cancer therapy in connection with its private placement of Series B-1 Preferred Stock and warrants; Represented company in connection with its private placement of Series B-1 Preferred Stock to an Asian venture capital firm; Represented company with its private placement of Series B-1 Preferred Stock to a Russian sovereign wealth backed private equity investor, and current investors; Represented company in connection with several convertible note financing transactions.
Advised EnerNOC, Inc., one of the largest providers of energy intelligence software and services for commercial, institutional, and industrial customers, as well as electric power grid operators and utilities, in its acquisition of Germany-based company accelerating its market expansion into continental Europe. Also advised EnerNOC, Inc., in its acquisitions of leading global utility bill management company addressing matters related to the acquisition of operations in the US and UK as well as their subsidiaries in Australia, Brazil, Canada, China, and India.
Brookstone $180M Sale of Assets
Represented Brookstone, a national specialty retailer of distinctive consumer products, in connection with the approximately $180M sale of substantially all of its assets to a consortium of Chinese investors following its filing for Bankruptcy protection.
Leader in Supply, Repair, and Servicing of Oil and Gas Fields Restructuring
Represented a leader in the supply, repair and servicing of oil and gas field, industrial, coal mine and agricultural products and equipment in connection with the restructuring of its credit facility; Represented the company in connection with the redemption of all of the issued and outstanding minority interests.
Paint Manufacturer Disposition of Assets
Represented manufacturer of non-toxic, high performance paint, in connection with the disposition of certain assets.
University Acquisition of Technology and IP Assets
Represented New England-based, internationally-recognized university in its acquisition of certain technology and intellectual property assets.
Allen & Gerritsen, Inc. Acquistion
Represented Allen & Gerritsen, Inc., a Boston, Massachusetts-based advertising agency, in its acquisition of another advertising firm. Closed senior and subordinated loan financings to support the acquisition.
eviti, Inc. Private Offering in Bridge Financings and Merger
Represented eviti, Inc., the creator of an evidence-based advanced decision support oncology platform, in connection with its private offering in a bridge financing of convertible promissory notes; Represented eviti, Inc. in connection with its merger with its principal stockholder.
Investment Management Firm Equity Financing
Represented an investment management firm focused on seeking solid financial returns from funds with lasting social and environmental impact in an equity financing with multiple closings.
Hydropower Company Equity Financing
Represented a leading New England-based hydropower company that develops, operates and manages small-scale regional and local hydroelectric facilities in its initial equity financing with multiple closings.
Financial Software and Technology Company Common Stock Offering
Represented a New York City-based financial software and technology company in a common stock offering to new and existing investors.
Family-Owned Supermarket Company Corporate Governance and Contractual Matters
Advised prominent New England-based family-owned supermarket company in connection with corporate governance and contractual matters during prolonged shareholder dispute and eventual ownership restructuring.